[Therapy of cardiogenic shock].
D000138:Acidosis / Q000150:complications; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001243:Assisted Circulation; D002302:Cardiac Output; D006336:Heart Massage; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D012121:Respiration, Artificial; D012770:Shock, Cardiogenic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D005996:Nitroglycerin
Therapie des kardiogenen Schocks.